Sunday, June 21, 2015 2:23:05 PM
Ontario Securities Commission lawyers are seeking fines and other payments totalling almost $6.8-million from former Bay Street lawyer Mitchell Finkelstein and four others involved in a high-profile tipping and insider trading case.
OSC staff asked a hearing panel Wednesday to order Mr. Finkelstein to pay $1.5-million for tipping long-time friend Paul Azeff about three pending takeover deals, but his lawyer told the commission his client cannot afford the cost. The OSC is also seeking lifetime bans that would prohibit Mr. Finkelstein from trading securities with exceptions for registered accounts like RRSPs, and from serving as a director or officer of a company.
image: http://static.theglobeandmail.ca/e5e/report-on-business/industry-news/the-law-page/article22068433.ece/ALTERNATES/w140/OSC-finkelstein11rb2.JPG
Kim Goodman, left, walks with Mitchell Finkelstein, alleged insider-trading tipping lawyer, in the hall way of the Ontario Securities Commission during his trial, Nov. 10, 2011.
Kim Goodman, left, walks with Mitchell Finkelstein, alleged insider-trading tipping lawyer, in the hall way of the Ontario Securities Commission during his trial, Nov. 10, 2011.Brett Gundlock for The Globe and Mail
Manley
Canada needs new tools to fight corporate wrongdoing
image: http://static.theglobeandmail.ca/cef/report-on-business/industry-news/the-law-page/article23610689.ece/ALTERNATES/w140/20111110bg_Finkelstien03.JPG
Mitchell Finkelstein in the hall way of the Ontario Securities Commission during his trial, November 10, 2011.
Mitchell Finkelstein in the hall way of the Ontario Securities Commission during his trial, November 10, 2011.For The Globe and Mail
news
Five things you need to know about the Finkelstein verdict
The commission cannot impose jail terms in cases that are conducted as administrative hearings.
Mr. Finkelstein’s lawyer, Gordon Capern, said his client has already faced terrible consequences by losing his job as a senior partner at law firm Davies Ward Phillips & Vineberg LLP, and said an additional $1.5-million fine “goes well beyond the line of punitive.”
He said Mr. Finkelstein, 45, has two children to provide for, and his “brief run of high income years at Davies” have ended.
“This is very much a young family struggling to get by,” Mr. Capern said.
OSC commissioner Alan Lenczner, who is heading the hearing panel, said Mr. Finkelstein has not filed any documentation about his current financial state, but Mr. Capern replied it can be inferred from the fact he lost his job and has had to pay for his defence in the case.
Mr. Capern also revealed that Mr. Finkelstein worked for a sole-practitioner real estate lawyer for two and a half years after leaving Davies, then took a job at a real estate development firm. He said that job ended “disastrously” after Mr. Finkelstein became aware of financial improprieties and alerted authorities.
Mr. Capern said Mr. Finkelstein made no profit from his tipping, and has suffered reputational harm from the publicity the case generated. He said the bans requested by OSC staff are unnecessary to protect the capital markets from further wrongdoing because Mr. Finkelstein will never “do anything or be exposed to anything” in the future that would give him access to similar insider information.
OSC lawyer Donna Campbell, however, said significant penalties are needed because there was “egregious conduct” and tipping and insider trading “are at the severe end” of offences under Ontario’s securities law. She said Mr. Finkelstein was a securities lawyer and the other four men were registrants approved to work in the financial industry, so all knew the severity of misusing insider information.
“Each had a gate-keeping role and a responsibility to the capital markets,” she said.
She said the OSC is seeking the greatest penalties against Mr. Finkelstein and Mr. Azeff because they were at the core of the tipping and insider trading, and the wrongdoing wouldn’t have happened if they had not passed along or acted on the information.
The OSC panel ruled in March that Mr. Azeff, a former investment adviser at CIBC in Montreal, learned about deals from Mr. Finkelstein and passing along the tips to his business partner, Korin Bobrow, and to other clients and family members.
OSC lawyers are seeking total monetary penalties of $5.7-million from the five people named in the case – including $2.25-million from Mr. Azeff – as well as costs of $1-million to cover the OSC’s expenses and repayment of $120,000 in trading profits.
Lawyer Tyler Hodgson, who is representing Mr. Azeff and Mr. Bobrow, said the proposed fine of $2.25-million for Mr. Azeff is far beyond the $49,996 he personally earned from trading securities in advance of three takeover deals named in the case. He said a fine in the case should be far lower and linked to the size of the profits earned.
Mr. Hodgson said the most significant penalty, however, is the OSC’s proposal to ban Mr. Azeff and Mr. Bobrow from being registrants who can work in the securities industry. Both men are currently working at investment firm Euro Pacific Canada Inc., and want the OSC to instead order that they have to work under “strict supervision” by their employer for the next 15 years.
Read more at http://www.stockhouse.com/companies/bullboard/v.int/intertainment-media-inc#e7EcV68HfTIyGJEJ.99
Recent CATX News
- Perspective Therapeutics to Participate at Upcoming May Investor Conferences • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
- Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs • GlobeNewswire Inc. • 04/30/2024 11:00:00 AM
- Perspective Therapeutics to Participate at Upcoming April Investor Conferences • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 03/28/2024 11:30:08 AM
- Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024 • GlobeNewswire Inc. • 03/11/2024 12:00:00 PM
- Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- Perspective Therapeutics Announces $87.4 Million Private Placement • GlobeNewswire Inc. • 03/04/2024 02:45:00 PM
- Perspective Therapeutics to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Perspective Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/12/2024 01:00:00 PM
- Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement • GlobeNewswire Inc. • 01/22/2024 09:05:00 PM
- Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement • GlobeNewswire Inc. • 01/18/2024 12:00:00 PM
- Perspective Therapeutics Announces Proposed Public Offering • GlobeNewswire Inc. • 01/17/2024 09:05:00 PM
- Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01 • GlobeNewswire Inc. • 01/17/2024 01:00:00 PM
- Another Healthcare Stock Stealing The Show • AllPennyStocks.com • 01/09/2024 09:10:00 PM
- Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability • GlobeNewswire Inc. • 01/09/2024 01:00:00 PM
- Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics • GlobeNewswire Inc. • 01/09/2024 01:00:00 PM
- Perspective Therapeutics Announces Exclusive License Agreement with Mayo Clinic for New Radiopharmaceutical Platform for Prostate Cancer Treatment • GlobeNewswire Inc. • 01/05/2024 01:00:00 PM
- Perspective Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/02/2024 01:00:00 PM
- Perspective Therapeutics Divests Brachytherapy Business • GlobeNewswire Inc. • 12/12/2023 01:00:00 PM
- Perspective Therapeutics Announces First Patient Dosed in a Phase 1 Study of [(212)Pb]VMT-α-NET to Treat Refractory or Relapsed Neuroendocrine Tumors • GlobeNewswire Inc. • 12/07/2023 01:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM